Grace Kavinsky

Grace Kavinsky is a litigator at Bartlit Beck, focusing her practice on high-stakes intellectual property and complex commercial disputes, particularly within the life sciences sector. Her experience includes patent litigation concerning advanced technologies such as liquid biopsy sequencing methods, cancer diagnostics, genomic analysis, and AI-driven precision medicine. She joined Bartlit Beck in 2025 after an associate role at a premier New York law firm and a clerkship with the Honorable Julie Rikelman on the United States Court of Appeals for the First Circuit.

Kavinsky demonstrates a balanced practice, representing both plaintiffs and defendants in patent matters. Her tracked appearances include serving as Trial Counsel for Tempus AI Inc. in a false advertising and unfair competition case against Guardant Health Inc., alleging misleading comparisons of liquid biopsy assays. Concurrently, she acted as Lead Counsel for Tempus AI, Inc. as a defendant in a patent infringement case brought by Guardant Health, Inc. These cases underscore her involvement in the highly competitive and technologically complex field of oncology diagnostics.

Her notable engagements include the ongoing "patent battle" between Tempus AI and Guardant Health, which involves patents related to methods for detecting genetic variants in cell-free DNA. These disputes have also involved inter partes review (IPR) proceedings at the Patent Trial and Appeal Board (PTAB), where she has been involved in challenging patent claims, such as IPR2025-01434 concerning methods for detecting genetic variants.

Ms. Kavinsky earned her J.D. from Stanford Law School in 2023 and a B.A., summa cum laude, from Washington University in St. Louis in 2020. She is admitted to practice in Illinois and New York.